{"id":2497,"date":"2018-07-06T10:33:06","date_gmt":"2018-07-06T08:33:06","guid":{"rendered":"https:\/\/www.anderapartners.com\/?p=2497"},"modified":"2020-10-07T19:58:40","modified_gmt":"2020-10-07T17:58:40","slug":"biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development","status":"publish","type":"post","link":"https:\/\/www.anderapartners.com\/en\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/","title":{"rendered":"BioDiscovery invests in Dynacure to advance lead program into clinical development"},"content":{"rendered":"

\"\"<\/p>\n

Dynacure, a biotechnology company developing new treatments for patients affected by serious orphan disorders, announced the completion of a \u20ac47 million financing round (US$55 million) to advance its lead program into clinical development. Andera Partners (formerly Edmond de Rothschild Investment Partners) led the financing round, joined by Pontifax, BPI, Kurma Partners and IdInvest Partners.<\/p>\n

Dynacure\u2019s lead drug program, Dyn101, is an antisense oligonucleotide therapy in development for the rare and often fatal muscle disease centronuclear myopathy (CNM). Dyn101 is being developed in collaboration with Ionis Pharmaceuticals, the leading biopharmaceutical company in RNA-targeted drug discovery.<\/p>\n

To read Dynacure’s official press release, please click here.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Dynacure, a biotechnology company developing new treatments for patients affected by serious orphan disorders, announced the completion of a \u20ac47 million financing round (US$55 million) to advance its lead program into clinical development. Andera Partners (formerly Edmond de Rothschild Investment Partners) led the financing round, joined by Pontifax, BPI, Kurma Partners and IdInvest Partners. Dynacure\u2019s…<\/p>\n","protected":false},"author":2,"featured_media":2503,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[123],"class_list":["post-2497","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biodiscovery-en"],"acf":[],"yoast_head":"\nBioDiscovery invests in Dynacure to advance lead program into clinical development - ANDERA PARTNERS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioDiscovery invests in Dynacure to advance lead program into clinical development - ANDERA PARTNERS\" \/>\n<meta property=\"og:description\" content=\"Dynacure, a biotechnology company developing new treatments for patients affected by serious orphan disorders, announced the completion of a \u20ac47 million financing round (US$55 million) to advance its lead program into clinical development. Andera Partners (formerly Edmond de Rothschild Investment Partners) led the financing round, joined by Pontifax, BPI, Kurma Partners and IdInvest Partners. Dynacure\u2019s...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/\" \/>\n<meta property=\"og:site_name\" content=\"ANDERA PARTNERS\" \/>\n<meta property=\"article:published_time\" content=\"2018-07-06T08:33:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-07T17:58:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/07\/Dynacure-4.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"341\" \/>\n\t<meta property=\"og:image:height\" content=\"188\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nicolas Delsert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nicolas Delsert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/\"},\"author\":{\"name\":\"Nicolas Delsert\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c\"},\"headline\":\"BioDiscovery invests in Dynacure to advance lead program into clinical development\",\"datePublished\":\"2018-07-06T08:33:06+00:00\",\"dateModified\":\"2020-10-07T17:58:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/\"},\"wordCount\":115,\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/07\/Dynacure-4.jpg\",\"articleSection\":[\"andera Life Sciences\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/\",\"name\":\"BioDiscovery invests in Dynacure to advance lead program into clinical development - ANDERA PARTNERS\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/07\/Dynacure-4.jpg\",\"datePublished\":\"2018-07-06T08:33:06+00:00\",\"dateModified\":\"2020-10-07T17:58:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/#primaryimage\",\"url\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/07\/Dynacure-4.jpg\",\"contentUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/07\/Dynacure-4.jpg\",\"width\":341,\"height\":188},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.anderapartners.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioDiscovery invests in Dynacure to advance lead program into clinical development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"name\":\"ANDERA PARTNERS\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\",\"name\":\"Andera Partners\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"contentUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"width\":107,\"height\":44,\"caption\":\"Andera Partners\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c\",\"name\":\"Nicolas Delsert\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g\",\"caption\":\"Nicolas Delsert\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioDiscovery invests in Dynacure to advance lead program into clinical development - ANDERA PARTNERS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/","og_locale":"en_US","og_type":"article","og_title":"BioDiscovery invests in Dynacure to advance lead program into clinical development - ANDERA PARTNERS","og_description":"Dynacure, a biotechnology company developing new treatments for patients affected by serious orphan disorders, announced the completion of a \u20ac47 million financing round (US$55 million) to advance its lead program into clinical development. Andera Partners (formerly Edmond de Rothschild Investment Partners) led the financing round, joined by Pontifax, BPI, Kurma Partners and IdInvest Partners. Dynacure\u2019s...","og_url":"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/","og_site_name":"ANDERA PARTNERS","article_published_time":"2018-07-06T08:33:06+00:00","article_modified_time":"2020-10-07T17:58:40+00:00","og_image":[{"width":341,"height":188,"url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/07\/Dynacure-4.jpg","type":"image\/jpeg"}],"author":"Nicolas Delsert","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Nicolas Delsert","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/#article","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/"},"author":{"name":"Nicolas Delsert","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c"},"headline":"BioDiscovery invests in Dynacure to advance lead program into clinical development","datePublished":"2018-07-06T08:33:06+00:00","dateModified":"2020-10-07T17:58:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/"},"wordCount":115,"publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/#primaryimage"},"thumbnailUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/07\/Dynacure-4.jpg","articleSection":["andera Life Sciences"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/","url":"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/","name":"BioDiscovery invests in Dynacure to advance lead program into clinical development - ANDERA PARTNERS","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/#primaryimage"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/#primaryimage"},"thumbnailUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/07\/Dynacure-4.jpg","datePublished":"2018-07-06T08:33:06+00:00","dateModified":"2020-10-07T17:58:40+00:00","breadcrumb":{"@id":"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/#primaryimage","url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/07\/Dynacure-4.jpg","contentUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/07\/Dynacure-4.jpg","width":341,"height":188},{"@type":"BreadcrumbList","@id":"https:\/\/www.anderapartners.com\/fr\/biodiscovery-invests-in-dynacure-to-advance-lead-program-into-clinical-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.anderapartners.com\/en\/"},{"@type":"ListItem","position":2,"name":"BioDiscovery invests in Dynacure to advance lead program into clinical development"}]},{"@type":"WebSite","@id":"https:\/\/www.anderapartners.com\/fr\/#website","url":"https:\/\/www.anderapartners.com\/fr\/","name":"ANDERA PARTNERS","description":"","publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.anderapartners.com\/fr\/#organization","name":"Andera Partners","url":"https:\/\/www.anderapartners.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","contentUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","width":107,"height":44,"caption":"Andera Partners"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c","name":"Nicolas Delsert","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g","caption":"Nicolas Delsert"}}]}},"_links":{"self":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts\/2497","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/comments?post=2497"}],"version-history":[{"count":0,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts\/2497\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/media\/2503"}],"wp:attachment":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/media?parent=2497"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/categories?post=2497"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}